Nk Arora
-
{
- All
- News
- Videos
-
"No Rise In Hospitalisation, Deaths": Covid Panel Chief On Surge In Cases
Amid a surge in COVID-19 cases in India and the detection of a subvariant JN.1, India SARS-CoV-2 Genomics Consortium (INSACOG) chief Dr NK Arora said that no additional dose of vaccine is needed against the subvariant at present.
-
"No New Wave, Don't Need To Worry": Centre's Covid Panel Chief To NDTV
Pointing out that there has been no increase in hospital admissions and the death count due to Covid, he said the new mutation of the virus is more contagious but isn't causing serious disease.
-
"Hybrid, Not Herd Immunity, Keeps India Safe": Covid Panel Chief Dr NK Arora To NDTV
India's fight against COVID-19 is shaping up much better than neighbouring China due to robust "hybrid immunity", the head of the country's vaccine task force told NDTV today in an exclusive interview.
-
India Should Keep Close Vigil On China's COVID-19 Rise: Covid Panel Chief
Amid the rising COVID cases in China, a top Indian health expert on Tuesday cautioned the people while asking them to keep a close vigil on the situation in the country.
-
Monkeypox Not As Contagious As COVID-19, Says Covid Panel Chief
Monkeypox outbreak has been witnessed in nearly 20 countries, however, no suspected cases of the disease have been detected in India so far, referring to which, a health expert on Wednesday said that it is not as contagious as COVID-19.
-
WHO Estimate Of India Deaths "Preposterous, Untenable": Covid Panel Chief
WHO also said they chose the mathematical model as many countries "still lack capacity for reliable mortality surveillance and therefore do not collect and generate the data needed to calculate excess mortality".
-
Variants Will Keep On Coming, Nothing To Panic About: Covid Panel Head
New COVID-19 variants will keep coming, however, the new variants aren't causing severe diseases or increasing the number of cases said Chairman of the COVID-19 working group of India said.
-
Anti-Covid Pill Shouldn't Be Given To Younger Population: Covid Panel Head
Molnupiravir used in treatment of Covid should not be administered to younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of Covid Working Group of National Technical Advisory Group on Immunisation (NTAGI)
-
Covaxin Shelf-Life Extension Not A Problem: Covid Task Force Chief
It is absolutely safe, underlined the head of the India's vaccine task force chief on the vexing question of extending the shelf life of Covid vaccine, Covaxin, being given to teenagers (15-18) under the national Covid immunisation programme.
-
Third Wave On, 75% Cases In Metros Are Omicron: Covid Task Force Boss
A large chunk of Omicron cases in India as the country faces a third wave of the COVID-19 pandemic have been reported from big cities, the head of the country's vaccine task force Dr NK Arora told NDTV today, adding the third wave is here.
-
Doctor In Charge Of India's Vaccine Plans Defends Delay In Boosters
The doctor heading India's vaccine rollout today defended the decision to delay a roll out of booster doses in the country. ''What is true for Israel, for Europe or North America may not be truly applicable here,'' said Dr. NK Arora.
-
Vaccines For At-Risk Children Next Month: Covid Panel Chief To NDTV
Vaccination for children with comorbities will begin in December and that will be followed by the vaccine rollout for healthy children, somewhere in the first quarter of next year, Dr NK Arora, chairman of the country's Covid Task Force, told NDTV.
-
Plan To Vaccinate Over 44 Crore Children Ready, Says Covid Panel Chief
With the emergency of new COVID-19 variant 'Omicron', COVID-19 task force chairman Dr N K Arora said that a comprehensive policy on the booster and additional doses of COVID-19 vaccine will be announced in two weeks.
-
Children With Comorbidities To Be Prioritised For Vaccination: Central Panel Chief
Once the COVID-19 vaccination drive for children commences in India, priority would be given to children with comorbidities however severe, said National Immunization Technical Advisory Group (NTAGI) Chairperson Dr NK Arora.
-
"Not Even Enough For...": Vaccine Panel Chief On Pfizer, Moderna Offers
All US-based vaccine makers are insisting on indemnity and liability clauses and Indias reluctance to meet them is slowing down their entry in the market, NK Arora, head of the governments vaccine panel told NDTV yesterday.
-
"No Rise In Hospitalisation, Deaths": Covid Panel Chief On Surge In Cases
Amid a surge in COVID-19 cases in India and the detection of a subvariant JN.1, India SARS-CoV-2 Genomics Consortium (INSACOG) chief Dr NK Arora said that no additional dose of vaccine is needed against the subvariant at present.
-
"No New Wave, Don't Need To Worry": Centre's Covid Panel Chief To NDTV
Pointing out that there has been no increase in hospital admissions and the death count due to Covid, he said the new mutation of the virus is more contagious but isn't causing serious disease.
-
"Hybrid, Not Herd Immunity, Keeps India Safe": Covid Panel Chief Dr NK Arora To NDTV
India's fight against COVID-19 is shaping up much better than neighbouring China due to robust "hybrid immunity", the head of the country's vaccine task force told NDTV today in an exclusive interview.
-
India Should Keep Close Vigil On China's COVID-19 Rise: Covid Panel Chief
Amid the rising COVID cases in China, a top Indian health expert on Tuesday cautioned the people while asking them to keep a close vigil on the situation in the country.
-
Monkeypox Not As Contagious As COVID-19, Says Covid Panel Chief
Monkeypox outbreak has been witnessed in nearly 20 countries, however, no suspected cases of the disease have been detected in India so far, referring to which, a health expert on Wednesday said that it is not as contagious as COVID-19.
-
WHO Estimate Of India Deaths "Preposterous, Untenable": Covid Panel Chief
WHO also said they chose the mathematical model as many countries "still lack capacity for reliable mortality surveillance and therefore do not collect and generate the data needed to calculate excess mortality".
-
Variants Will Keep On Coming, Nothing To Panic About: Covid Panel Head
New COVID-19 variants will keep coming, however, the new variants aren't causing severe diseases or increasing the number of cases said Chairman of the COVID-19 working group of India said.
-
Anti-Covid Pill Shouldn't Be Given To Younger Population: Covid Panel Head
Molnupiravir used in treatment of Covid should not be administered to younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of Covid Working Group of National Technical Advisory Group on Immunisation (NTAGI)
-
Covaxin Shelf-Life Extension Not A Problem: Covid Task Force Chief
It is absolutely safe, underlined the head of the India's vaccine task force chief on the vexing question of extending the shelf life of Covid vaccine, Covaxin, being given to teenagers (15-18) under the national Covid immunisation programme.
-
Third Wave On, 75% Cases In Metros Are Omicron: Covid Task Force Boss
A large chunk of Omicron cases in India as the country faces a third wave of the COVID-19 pandemic have been reported from big cities, the head of the country's vaccine task force Dr NK Arora told NDTV today, adding the third wave is here.
-
Doctor In Charge Of India's Vaccine Plans Defends Delay In Boosters
The doctor heading India's vaccine rollout today defended the decision to delay a roll out of booster doses in the country. ''What is true for Israel, for Europe or North America may not be truly applicable here,'' said Dr. NK Arora.
-
Vaccines For At-Risk Children Next Month: Covid Panel Chief To NDTV
Vaccination for children with comorbities will begin in December and that will be followed by the vaccine rollout for healthy children, somewhere in the first quarter of next year, Dr NK Arora, chairman of the country's Covid Task Force, told NDTV.
-
Plan To Vaccinate Over 44 Crore Children Ready, Says Covid Panel Chief
With the emergency of new COVID-19 variant 'Omicron', COVID-19 task force chairman Dr N K Arora said that a comprehensive policy on the booster and additional doses of COVID-19 vaccine will be announced in two weeks.
-
Children With Comorbidities To Be Prioritised For Vaccination: Central Panel Chief
Once the COVID-19 vaccination drive for children commences in India, priority would be given to children with comorbidities however severe, said National Immunization Technical Advisory Group (NTAGI) Chairperson Dr NK Arora.
-
"Not Even Enough For...": Vaccine Panel Chief On Pfizer, Moderna Offers
All US-based vaccine makers are insisting on indemnity and liability clauses and Indias reluctance to meet them is slowing down their entry in the market, NK Arora, head of the governments vaccine panel told NDTV yesterday.
